Maria L Garcia

This inventor holds 14 USPTO granted patents and 1 published patent application. Top assignees: Merck + Co., Inc., Evotec Oai. Active years: 1990-2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Maria L Garcia. Retrieved from https://idiyas.com/inventor/maria-l-garcia

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 14 (Patent Applications = 1)

% Patents Active = 50.0

Average Co-Inventor Count = 4.3

ph-index = 4

Forward Citations = 87(Granted Patents)

Location History:

Rahway, NJ (US) (1998)
Edison, NJ (US) (1990 - 2008)

Company Filing History:

where one patent can have more than one assignee

Years Active: 1990-2008

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7414067 - Ophthalmic compositions for treating ocular hypertension (2008-08-19),

2. 7294646 - Maxi-k channel blockers, methods of use and process for making the same (2007-11-13),

3. 6924306 - Method for treating ocular hypertension (2005-08-02),

4. 6914070 - Ophthalmic compositions for treating ocular hypertension (2005-07-05),

5. 6864383 - Ophthalmic compositions for treating ocular hypertension (2005-03-08),

6. 6632836 - Carbocyclic potassium channel inhibitors (2003-10-14),

7. 6548535 - Method for treating ocular hypertension (2003-04-15),

8. 6545036 - Ophthalmic compositions for treating ocular hypertension (2003-04-08),

9. 5776734 - DNA encoding the .beta. subunit of a mammalian maxi-K potassium channel (1998-07-07),

10. 5637470 - Screening array using cells expressing recombinant .alpha. and .beta. (1997-06-10),

11. 5541208 - Indole diterpene alkaloid compounds (1996-07-30),

12. 5494895 - Scorpion peptide margatoxin with immunosuppressant activity (1996-02-27),

13. 5399587 - Biologically active compounds (1995-03-21),

14. 4960867 - Leiurus quinquestriatus venom peptide inhibitor of calcium activated (1990-10-02),

Title: Maria L Garcia: Innovator in Ophthalmic Treatments

Introduction

Maria L Garcia is a prominent inventor based in Edison, NJ, with a remarkable portfolio of 14 patents. Her work primarily focuses on ophthalmic compositions aimed at treating ocular hypertension and related conditions. Garcia's innovative contributions have significantly advanced the field of eye care, particularly in the treatment of glaucoma.

Latest Patents

Among her latest patents, Garcia has developed formulations that utilize potent potassium channel blockers for the treatment of glaucoma. One notable invention is an ophthalmic composition designed to address elevated intraocular pressure in patients. This invention not only targets the treatment of glaucoma but also aims to provide a neuroprotective effect to the eyes of mammalian species, especially humans. Another significant patent involves maxi-k channel blockers, which similarly focus on treating conditions related to elevated intraocular pressure while offering neuroprotective benefits.

Career Highlights

Throughout her career, Maria L Garcia has worked with esteemed organizations such as Merck & Company, Inc. and Evotec OAI. Her experience in these companies has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research and development in ophthalmology.

Collaborations

Garcia has collaborated with notable colleagues, including Gregory J Kaczorowski and Owen B McManus. These partnerships have fostered a dynamic exchange of ideas and expertise, further enhancing her innovative work in the field.

Conclusion

Maria L Garcia's contributions to ophthalmic treatments through her patents and collaborations highlight her significant impact on eye care. Her dedication to innovation continues to pave the way for advancements in the treatment of ocular conditions.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent pending: